Identify the clinical and radiographic features (older age, progressive exertional dyspnea, persistent bibasilar inspiratory Velcro crackles, peripheral reticulation, traction bronchiectasis) that warrant prompt high-resolution CT and interstitial lung disease evaluation rather than continued empiric management of COPD or recurrent infection. Classify fibrotic ILD cases using the 2022 ATS/ERS/JRS/ALAT high-resolution CT pattern categories and determine the appropriate next diagnostic action, including referral for multidisciplinary discussion when the pattern is indeterminate or an alternative diagnosis is suspected. Differentiate IPF from fibrotic mimickers (fibrotic hypersensitivity pneumonitis, connective-tissue-disease associated ILD, fibrotic NSIP) using exposure history, serologic evaluation, and imaging features, and identify patients with IPF or progressive pulmonary fibrosis for whom antifibrotic therapy is indicated.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Foot & Ankle Surgery
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Laryngology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Transplant Surgery
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 4 credits
- MOC · Up to 4 points
- Commercial Support
-
ReleasedJul 1, 2026
-
Last day to claim creditJul 2, 2027 9 months left
-
American College of Chest Physicians October 2026: Association of Recovery Rate From Exertional Desaturation With Disease Progression and Mortality Risk in Patients With Fibrotic Interstitial Lung Disease
-
Medscape, LLC Feuding With Fibrosing ILD: Pathways to Timely Diagnosis and Care
-
PRIME Education, Inc. (PRIME®) Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Diagnosis of IPF
-
The Association of Pulmonary Advanced Practice Providers (APAPP) +1 Fibrosing ILDs on the Frontlines: IPF Management Across the Care Continuum
-
PFF +1 PFF Summit 2025 Enduring Evidence to Practice ILD Guidelines and Progressive Pulmonary Fibrosis
-
The Association of Pulmonary Advanced Practice Providers (APAPP) +1 Fibrosing ILDs on the Frontlines: Updates and Advances in Managing IPF
